|
|
 |
Registry of Lobbyists - Jeffrey Malawski
To find further information on a company or organization check the Registry of Joint Stock Companies
|
|
| Registration Number | Status | | | 1140 | Terminated | | | Initial registration date | Last date of any changes | | 16-July-2013 | 22-January-2015 |
|
Lobbyist's Last Name
Malawski |
Lobbyist's First Name
Jeffrey |
Middle Initial
|
|
Business Address of Lobbyist
16750 TransCanada Highway |
City
Kirkland |
Province/State
PQ |
Country
CA |
Postal/Zip Code
H9H 4M7 |
Telephone
514-428-2783 |
Fax
(514) 428-4926 |
| |
Business or Firm Name for Lobbyist (if applicable)
Merck Canada Inc. |
Registry of Joint Stock Companies Number
3242543 |
Business Address of Lobbyist's Business or Firm
16750 TransCanada Highway |
City
Kirkland |
Province/State
PQ |
Country
CA |
Postal/Zip Code
H9H 4M7 |
Telephone
|
Fax
(514) 428-4955 |
|
| Beneficiary Name |
Beneficiary Type |
|
| Merck Frosst Company / Compagnie Merck Frosst |
Parent Company |
View
|
|
|
|
|
Description of Employer's Business:
Today’s Merck is working to help the world be well. Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines and animal health products. In Canada, Merck markets more than 250 pharmaceutical and animal health products. Merck is a leader in a broad range of areas such as cardiology, infectious diseases, respiratory, vaccines and women's health, and is focused on expanding offerings in other areas, including virology, oncology and diabetes.
Based in Montréal, Québec, Merck employs approximately 975 people across Canada. The Merck Canada manufacturing facility in Québec has been designated by its parent company as a Centre of Excellence for the global production of liquids, ointments and creams. Merck is one of the top R&D investors in Canada, with investments totalling $22.6 million in 2013 and more than $1 billion since 2000. For more information about our operations in Canada, visit www.merck.ca. |
| |
|
|
|
| Description |
|
| To actively promote the value of the pharmaceutical industry for the Province's economic health and well-being, but most importantly for the health and well-being of its citizens. As part of this initiative, Merck Canada Inc. seeks to have its products listed on the Nova Scotia Drug Products Formulary and have publicly funded immunization programs. |
View
|
|
|
|
|
|
No funding from any government or agency
|
|
No private funding related to lobbying activities
|
|
|
|
|
